Skip to main content

Table 2 Hemodynamic parameters of the 11 patients

From: Use of low-dose β1-blocker for sinus tachycardia in patients with catecholamine support following cardiovascular surgery: a retrospective study

 

Pre-landiolol

Post-landiolol

p-value

HR

126.0 ± 7.6

112.4 ± 5.8

< 0.001

SVI

18.9 ± 4.2

22.4 ± 5.4

0.04

SV

30.8 ± 6.6

36.7 ± 10.5

0.033

CI

2.4 ± 0.5

2.5 ± 0.6

0.32

CO

3.9 ± 0.8

4.1 ± 1.1

0.28

SvO2

63.1 ± 12.8

65.2 ± 13.3

0.42

sBP

86.6 ± 29.1

102.8 ± 19.6

0.082

dBP

54.9 ± 10.5

59.3 ± 8.7

0.11

mBP

80.3 ± 18.8

81.5 ± 15.7

0.71

sPAP

28.6 ± 5.1

29.6 ± 8.8

0.51

dPAP

20.3 ± 4.9

18.9 ± 5.6

0.14

mPAP

21.1 ± 7.6

22.5 ± 6.5

0.53

CVP

10.4 ± 3.6

10.5 ± 5.1

0.91

BT

37.4 ± 0.8

37.6 ± 0.6

0.17

  1. Values represent mean ± SD. Change in HR is one of the coprimary end points
  2. HR heart rate (beats/min), SVI stroke volume index (mL/m2), SV stroke volume (mL); CI cardiac index (L/min/m2), CO cardiac output (L/min), SvO2 mixed venous oxygen saturation (%), sBP systolic arterial blood pressure (mmHg), dBP diastolic arterial pressure (mmHg), mBP mean arterial blood pressure (mmHg), sPAP systolic pulmonary artery pressure (mmHg), dPAP diastolic pulmonary artery pressure (mmHg), mPAP mean pulmonary artery pressure (mmHg), CVP central venous pressure (mmHg), BT blood temperature (°C)